𝔖 Bobbio Scriptorium
✦   LIBER   ✦

“Theory of mind” is impaired in Huntington's disease

✍ Scribed by Martin Brüne; Karina Blank; Henning Witthaus; Carsten Saft


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
118 KB
Volume
26
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background:

Huntington's disease (HD) is an autosomal dominant degenerative brain disorder that is characterized by motor, cognitive, and affective symptoms. There is, to some, degree, phenomenological overlap with schizophrenia. Schizophrenia patients are frequently impaired in “theory of mind” (ToM), that is, the ability to reflect on the mental states of self and others, with mixed evidence for a ToM deficit in HD.

Methods:

We examined ToM and neurocognitive functioning in 25 patients diagnosed with HD. For comparison, 25 patients with schizophrenia and 25 healthy controls, matched for age and gender, were included.

Results:

Patients with HD were impaired in ToM relative to controls. The pattern of neurocognitive deficits including ToM strikingly resembled the one found in schizophrenia, suggesting a selectively impaired ToM. In contrast to previous schizophrenia research, ToM was not associated with functional measures on the Unified Huntington's Disease Rating Scale (UHDRS).

Conclusions:

The present study shows that patients with HD have deficits in ToM similar to schizophrenia. The association of impaired ToM with function needs to be established in future studies using rating scales that more specifically address interpersonal problems. © 2011 Movement Disorder Society


📜 SIMILAR VOLUMES


Assessment of simple movements reflects
✍ Carsten Saft; Jürgen Andrich; Nina-Marie Meisel; Horst Przuntek; Thomas Müller 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

Clinical rating, caudate atrophy, disturbed movement performance, neuropsychological testing, and age-related genetic disease load (CAG index) are tools that reflect impairment after onset of Huntington's disease (HD). Objectives were to compare scored HD symptoms, results of neuropsychological test

Impaired modulation of the vestibulo-ocu
✍ Joanne Fielding; Nellie Georgiou-Karistianis; John Bradshaw; Lynette Millist; An 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

## Abstract The vestibulo‐ocular reflex (VOR) stabilizes gaze during movement, in conjunction with other afferent information: visual, proprioceptive, and somaesthetic. The reflex can either be augmented or suppressed, depending on visual requirements, and undergoes long‐term adaptation to compensa

Spectrum of gait impairments in presympt
✍ Ashwini K. Rao; Lisa Muratori; Elan D. Louis; Carol B. Moskowitz; Karen S. Marde 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

## Abstract The purpose of this study was to quantify gait impairments in presymptomatic and symptomatic Huntington's disease (HD) subjects, and examine sensitivity of gait measures. Our sample (n = 65) included presymptomatic mutation carriers (PMC) (n = 15), symptomatic HD subjects (SHD) (n = 30)

Impaired postural stability as a marker
✍ Danielle Salomonczyk; Robert Panzera; Eva Pirogovosky; Jody Goldstein; Jody Core 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 1 views

## Abstract Subtle changes in fine motor control have been observed in individuals who carry the Huntington's disease (HD) mutation but have not yet manifested symptoms, referred to as premanifest HD (preHD). However, few studies have examined gross motor impairments in this population. This study

Effects of rivastigmine on motor and cog
✍ Marina de Tommaso; Nicola Specchio; Vittorio Sciruicchio; Olimpia Difruscolo; Lu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 1 views

## Abstract To evaluate the efficacy of rivastigmine on motor and cognitive impairment in Huntington's disease (HD), we carried out a prospective, open‐label, randomized, controlled study. Twenty‐one HD patients were enrolled: 14 were randomly sorted into medication and 7 to no‐treatment groups. Cl